INS and type 1 diabetes mellitus: Therefore, we believe that the addition of the empagliflozin/metformin combination to insulin treatment could be beneficial in the group of people with type 1 diabetes characterized by increased weight, elevated cardiovascular risk, and poorly controlled glycemia.